Cargando…
P369: DONOR-DERIVED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1 TRIAL
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429299/ http://dx.doi.org/10.1097/01.HS9.0000968388.54603.34 |
| _version_ | 1785090677091074048 |
|---|---|
| author | Luo, Yi Gao, Lei Liu, Jia Yang, Luxin Wang, Lu Lai, Xiaoyu Gao, Shichun Liu, Lizhen Zhao, Lu Ye, Yishan Wang, Manning Liao, Shengyu Shen, Lianjun William Cao, Wei Wang, Dongrui LI, Wenling Zhang, XI Huang, He |
| author_facet | Luo, Yi Gao, Lei Liu, Jia Yang, Luxin Wang, Lu Lai, Xiaoyu Gao, Shichun Liu, Lizhen Zhao, Lu Ye, Yishan Wang, Manning Liao, Shengyu Shen, Lianjun William Cao, Wei Wang, Dongrui LI, Wenling Zhang, XI Huang, He |
| author_sort | Luo, Yi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429299 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104292992023-08-17 P369: DONOR-DERIVED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1 TRIAL Luo, Yi Gao, Lei Liu, Jia Yang, Luxin Wang, Lu Lai, Xiaoyu Gao, Shichun Liu, Lizhen Zhao, Lu Ye, Yishan Wang, Manning Liao, Shengyu Shen, Lianjun William Cao, Wei Wang, Dongrui LI, Wenling Zhang, XI Huang, He Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429299/ http://dx.doi.org/10.1097/01.HS9.0000968388.54603.34 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Luo, Yi Gao, Lei Liu, Jia Yang, Luxin Wang, Lu Lai, Xiaoyu Gao, Shichun Liu, Lizhen Zhao, Lu Ye, Yishan Wang, Manning Liao, Shengyu Shen, Lianjun William Cao, Wei Wang, Dongrui LI, Wenling Zhang, XI Huang, He P369: DONOR-DERIVED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1 TRIAL |
| title | P369: DONOR-DERIVED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1 TRIAL |
| title_full | P369: DONOR-DERIVED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1 TRIAL |
| title_fullStr | P369: DONOR-DERIVED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1 TRIAL |
| title_full_unstemmed | P369: DONOR-DERIVED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1 TRIAL |
| title_short | P369: DONOR-DERIVED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1 TRIAL |
| title_sort | p369: donor-derived anti-cd19 chimeric antigen receptor t cells for b-cell acute lymphoblastic leukemia: a phase 1 trial |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429299/ http://dx.doi.org/10.1097/01.HS9.0000968388.54603.34 |
| work_keys_str_mv | AT luoyi p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT gaolei p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT liujia p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT yangluxin p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT wanglu p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT laixiaoyu p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT gaoshichun p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT liulizhen p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT zhaolu p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT yeyishan p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT wangmanning p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT liaoshengyu p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT shenlianjun p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT williamcaowei p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT wangdongrui p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT liwenling p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT zhangxi p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial AT huanghe p369donorderivedanticd19chimericantigenreceptortcellsforbcellacutelymphoblasticleukemiaaphase1trial |